Cardiolyse is one of 6 international startups chosen among over 350 applicants, that will participate in the Health&BioTech Accelerator’s program coordinated by Deloitte Officine Innovazione in collaboration with MSD Italia, Intesa Sanpaolo RBM Salute, and some of the largest private healthcare providers in the Country such as Gruppo San Donato.
The initiative is also supported by the clinical partners Humanitas and Santagostino, by the Italian Institue of Technology, the University of Milan and IFOM as scientific partners, by the supporting partner Life Science District and by Smau, Digital Innovation Days, Notizie.it, Makinglife and InnovUp as ecosystem partners; while Panakés Partners, Digital Magics and Italian Angels for Growth are supporting the program as investment partners.
We have begun working on our pilot project together with the corporate partners, the Deloitte team and the scientific, clinical and financial partners. The whole program is developed in a fully virtual framework which will allow the startups to have full and constant interaction with all the project’s partners during the weeks of acceleration.
The program will culminate in the DemoDay, in July 2022. During this event, the startups will pitch to the innovation ecosystem and to the investors' community.
For more information, visit Health & BioTech Accelerator website.
